U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07234318) titled 'Non-interventional Study to Evaluate the Anti-inflammatory Effects and the Clinical Efficacy of Topical Water Free Cyclosporin 0.1% Eye Drops in Patients With Dry Eye Disease and Associated Ocular Surface Inflammation Non-responding to Artificial Tears' on Nov. 14.
Brief Summary: The FOCUS study aims to evaluate the clinical efficacy of 0.1% cyclosporine eye drops solution (Vevizye(R), Laboratoires THEA) in patients with moderate to severe dry eye disease characterized by ocular surface inflammation.
Study Start Date: Dec. 15
Study Type: OBSERVATIONAL
Condition:
Dry Eye Disease (DED)
Intervention:
DRUG: Cyclosporin
This medic...